跳至主要内容
临床试验/NCT02515149
NCT02515149已完成不适用

Randomized Controlled Trial to Assess Accuracy, Feasibility, Acceptability, Cost Effectiveness and Impact of Point of Care CD4 Testing on HIV Diagnosis, Linkage to Care and Time to Antiretroviral Therapy Initiation Among HIV Infected Patients in Rural Western Kenya

Centers for Disease Control and Prevention1 个研究点 分布在 1 个国家目标入组 770 人开始时间: 2013年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
770
试验地点
1
主要终点
Linkage to HIV care

研究概览

简要总结

Randomised Controlled Trial to Assess Accuracy, Feasibility, Acceptability, Cost Effectiveness and Impact of Point of Care CD4 Testing on HIV Diagnosis, Linkage to Care and Time to Antiretroviral Therapy Initiation among HIV Infected Patients in Rural Western Kenya.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
None

入排标准

性别
All
接受健康志愿者
否

入选标准

  • •adults living in the study catchment area (Gem Village, Nyanza province Western Kenya) served by one of 23 HIV clinics and 3 referral labs
  • •Not having received HIV care in prior 6 months if known HIV+

排除标准

  • •current HIV care or HIV care within last six months

研究组 & 干预措施

Standard of care

No Intervention

Referral laboratory based CD4 measurement after home-based HIV testing

Point of care

Experimental

POC CD4 testing after home-based HIV testing

干预措施: Point of care CD4 device (Alere PIMA) (Device)

结局指标

主要结局

Linkage to HIV care

时间窗: Within six months from date of study enrollment

As ascertained from clinic charts

ART initiation

时间窗: Within six months from date of study enrollment

As ascertained from clinic charts

次要结局

未报告次要终点

研究者

发起方
Centers for Disease Control and Prevention
申办方类型
Fed
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验